Company news

Einbeck, 2025-02-27

An infestation with clubroot endangers oilseed rape crops worldwide. Depending on different environmental factors, maximum yield losses are possible. However, the resistance to the disease of previous varieties is becoming increasingly less effective. With PBR1, KWS has now identified and decoded a completely new resistance gene and crossed it into the first varieties. The new genetics are very promising – this is also confirmed by official trial data from renowned agricultural institutes in Germany and France.

Einbeck, 2025-02-21

The 2024 Kaiserring Fellowship was awarded to Ukrainian multimedia artist Daria Koltsova. The works from her exhibition at the Mönchehaus Museum in Goslar will be complemented by additional pieces and installations, and will be on display starting February 27 at the NEWCOMER KWS ART Lounge.

Einbeck, 2025-02-13

- Net sales rise by 5%, in particular due to early sales - Key earnings indicators negative due to seasonality, clear improvement in cash flow - One-time gain (around €100 million after taxes) and significantly lower net debt due to business divestment in South America (Q1 2024/2025) - Forecasts for fiscal year 2024/2025 confirmed

Einbeck, 2025-02-11

Various participants from the industry have set themselves the goal with the “Meat Climate Platform” of finding a Germany-wide industry solution for reducing greenhouse gas emissions in meat production by 2025. With the successful certification of the sustainable feeding concept for pigs, KWS has now taken the first important step toward this solution.

Einbeck, 2025-01-28

- Volume of EUR 200 million with a term of five years - Consideration of sustainability indicators - Loan agreement without financial covenants

Einbeck, 2025-01-10

Due to legal complaints driven by United Beet Seeds BV, KWS takes a clear position on intellectual property related to its CR+® trait in sugarbeet.

Einbeck, 2024-12-05

At today's Annual Shareholders’ Meeting, the shareholders of KWS SAAT SE & Co. KGaA (ISIN: DE0007074007) approved the management's proposed resolutions on all items on the agenda with a clear majority. The dividend payout for fiscal year 2023/2024 will rise to €1.00 (0.90) per share with a payout ratio of 25.2% (23.4%).

Einbeck, 2024-12-01

KWS lives its enthusiasm for Life Science every day. The leading company in plant breeding and seed production has been committed to sustainable agricultural solutions for almost 170 years. This is implemented worldwide in over 70 countries, while there is a clear commitment to the Einbeck location and its local roots.

Einbeck, 2024-11-14

The viewer catches a final glimpse of the lush blossoms at the peak of their splendor. The large-format works by Luzia Simons become a feast for the eyes. The layered cut flowers, in their opulence, attain an almost overwhelming presence—a symbol of beauty and transience. By staging the blooms against a velvety, dark background, the tulips and chrysanthemums acquire a sculptural quality, conveying a tension-filled aura between extreme closeness and great distance.

Einbeck, 2024-11-12

Strong sales growth of 18% due to early sales - Key earnings figures improved (negative due to business seasonality) - One-time gain of €110 million from divestment of corn and sorghum business in South America - Net debt significantly decreased by around €500 million year-on-year Forecast for the 2024/2025 financial year confirmed

Einbeck, 2024-11-07

6-R, a project funded by the Federal Ministry of Food and Agriculture (BMEL), has demonstrated the positive effects of high rye content in compound feed concepts for pigs. Now the BMEL has given the green light for another research project: FUETURE will evaluate the benefits of resource-efficient animal feed in poultry farming.

Einbeck, 2024-11-05

Seed specialist KWS is announcing two new Executive Board members to complete and rejuvenate the management team as from 2025. KWS is thus setting the course for the company’s continuous and future-oriented development. In 2025, both Eva Kienle (at the end of January) and Dr. Peter Hofmann (at the end of September) will leave the Executive Board of the company as planned.